143 related articles for article (PubMed ID: 38320555)
1. The cyclimids: Degron-inspired cereblon binders for targeted protein degradation.
Ichikawa S; Payne NC; Xu W; Chang CF; Vallavoju N; Frome S; Flaxman HA; Mazitschek R; Woo CM
Cell Chem Biol; 2024 Jun; 31(6):1162-1175.e10. PubMed ID: 38320555
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cereblon-dependent targeted protein degrader by visualizing the spatiotemporal ternary complex formation in cells.
Kaji T; Koga H; Kuroha M; Akimoto T; Hayata K
Sci Rep; 2020 Feb; 10(1):3088. PubMed ID: 32080280
[TBL] [Abstract][Full Text] [Related]
3. A Cell-Based Target Engagement Assay for the Identification of Cereblon E3 Ubiquitin Ligase Ligands and Their Application in HDAC6 Degraders.
Yang K; Zhao Y; Nie X; Wu H; Wang B; Almodovar-Rivera CM; Xie H; Tang W
Cell Chem Biol; 2020 Jul; 27(7):866-876.e8. PubMed ID: 32413286
[TBL] [Abstract][Full Text] [Related]
4. The E3 ligase adapter cereblon targets the C-terminal cyclic imide degron.
Ichikawa S; Flaxman HA; Xu W; Vallavoju N; Lloyd HC; Wang B; Shen D; Pratt MR; Woo CM
Nature; 2022 Oct; 610(7933):775-782. PubMed ID: 36261529
[TBL] [Abstract][Full Text] [Related]
5. Modeling the CRL4A ligase complex to predict target protein ubiquitination induced by cereblon-recruiting PROTACs.
Bai N; Riching KM; Makaju A; Wu H; Acker TM; Ou SC; Zhang Y; Shen X; Bulloch DN; Rui H; Gibson BW; Daniels DL; Urh M; Rock BM; Humphreys SC
J Biol Chem; 2022 Apr; 298(4):101653. PubMed ID: 35101445
[TBL] [Abstract][Full Text] [Related]
6. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
7. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs.
Steinebach C; Bricelj A; Murgai A; Sosič I; Bischof L; Ng YLD; Heim C; Maiwald S; Proj M; Voget R; Feller F; Košmrlj J; Sapozhnikova V; Schmidt A; Zuleeg MR; Lemnitzer P; Mertins P; Hansen FK; Gütschow M; Krönke J; Hartmann MD
J Med Chem; 2023 Nov; 66(21):14513-14543. PubMed ID: 37902300
[TBL] [Abstract][Full Text] [Related]
8. Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs.
Girardini M; Maniaci C; Hughes SJ; Testa A; Ciulli A
Bioorg Med Chem; 2019 Jun; 27(12):2466-2479. PubMed ID: 30826187
[TBL] [Abstract][Full Text] [Related]
9. Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs.
Min J; Mayasundari A; Keramatnia F; Jonchere B; Yang SW; Jarusiewicz J; Actis M; Das S; Young B; Slavish J; Yang L; Li Y; Fu X; Garrett SH; Yun MK; Li Z; Nithianantham S; Chai S; Chen T; Shelat A; Lee RE; Nishiguchi G; White SW; Roussel MF; Potts PR; Fischer M; Rankovic Z
Angew Chem Int Ed Engl; 2021 Dec; 60(51):26663-26670. PubMed ID: 34614283
[TBL] [Abstract][Full Text] [Related]
10. Development of Phenyl-substituted Isoindolinone- and Benzimidazole-type Cereblon Ligands for Targeted Protein Degradation.
Nie X; Zhao Y; Tang H; Zhang Z; Liao J; Almodovar-Rivera CM; Sundaresan R; Xie H; Guo L; Wang B; Guan H; Xing Y; Tang W
Chembiochem; 2024 Feb; 25(4):e202300685. PubMed ID: 38116854
[TBL] [Abstract][Full Text] [Related]
11. Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera.
Kim K; Lee DH; Park S; Jo SH; Ku B; Park SG; Park BC; Jeon YU; Ahn S; Kang CH; Hwang D; Chae S; Ha JD; Kim S; Hwang JY; Kim JH
Sci Rep; 2019 Dec; 9(1):19654. PubMed ID: 31873151
[TBL] [Abstract][Full Text] [Related]
12. A synthetic KLHL20 ligand to validate CUL3
Farrell BM; Gerth F; Yang CR; Yeh JT
Genes Dev; 2022 Sep; 36(17-18):1031-1042. PubMed ID: 36328355
[TBL] [Abstract][Full Text] [Related]
13. Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation.
Xie H; Li C; Tang H; Tandon I; Liao J; Roberts BL; Zhao Y; Tang W
J Med Chem; 2023 Feb; 66(4):2904-2917. PubMed ID: 36749666
[TBL] [Abstract][Full Text] [Related]
14. Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon.
Heim C; Spring AK; Kirchgäßner S; Schwarzer D; Hartmann MD
Biochem Biophys Res Commun; 2022 Dec; 637():66-72. PubMed ID: 36375252
[TBL] [Abstract][Full Text] [Related]
15. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
16. Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron.
Heim C; Spring AK; Kirchgäßner S; Schwarzer D; Hartmann MD
Biochem Biophys Res Commun; 2023 Feb; 646():30-35. PubMed ID: 36701892
[TBL] [Abstract][Full Text] [Related]
17. Development of a covalent cereblon-based PROTAC employing a fluorosulfate warhead.
Nowak RP; Ragosta L; Huerta F; Liu H; Ficarro SB; Cruite JT; Metivier RJ; Donovan KA; Marto JA; Fischer ES; Zerfas BL; Jones LH
RSC Chem Biol; 2023 Nov; 4(11):906-912. PubMed ID: 37920397
[TBL] [Abstract][Full Text] [Related]
18. Selective Degradation of GSPT1 by Cereblon Modulators Identified via a Focused Combinatorial Library.
Powell CE; Du G; Che J; He Z; Donovan KA; Yue H; Wang ES; Nowak RP; Zhang T; Fischer ES; Gray NS
ACS Chem Biol; 2020 Oct; 15(10):2722-2730. PubMed ID: 32865967
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Characterization of a Novel Cereblon-Recruiting PRC1 Bridged PROTAC Degrader.
Kabir M; Qin L; Luo K; Xiong Y; Sidi RA; Park KS; Jin J
J Med Chem; 2024 Apr; 67(8):6880-6892. PubMed ID: 38607318
[TBL] [Abstract][Full Text] [Related]
20. General Stepwise Approach to Optimize a TR-FRET Assay for Characterizing the BRD/PROTAC/CRBN Ternary Complex.
Lin W; Chen T
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):941-952. PubMed ID: 33860212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
